A revolutionary vaccine that could prevent cancer for people at high risk of bowel and ovarian cancer has been developed.

The jab targets patients with Lynch syndrome, who are at high risk of bowel and ovarian cancer

Stay up to date with notifications from The IndependentNotifications can be managed in browser preferences.Jump to contentThank you for registeringPlease refresh the page or…

A revolutionary vaccine that could prevent cancer for people at high risk of bowel and ovarian cancer has been developed.